Probiotics as regulators of inflammation: A review

Functional Foods in Health and Disease

Volumn 4, Issue 7, 2014, Pages 299-311

  Lescheid, David W ^a  

^a NONE   (Germany)

Author keywords

Antimicrobial peptides; Butyrate; Cytokines; Endotoxemia; Epithelial; Immune; Inflammation; Probiotics

Indexed keywords

EID: 84996519646     PISSN: 23787007     EISSN: 21603855     Source Type: Journal    
DOI: 10.31989/ffhd.v4i7.2     Document Type: Review

References (65)

1. Honad K, Littman DR: The Microbiome in Infectious Disease and Inflammation. Ann Rev Immunol 2012,30:758-795.
2. Claros TG, Chang S, Gilliam EA, Maitra U, Deng H, Li L: Causes and consequences of low grade endotoxemia and inflammatory diseases. Front Biosci (Schol Ed.) 2013,5:754-765.
3. Cani PD, Osto M, Geurts L, Everard A: Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 2012,3(4):279-288.
4. Pussinen PJ, Havulinna AS, Lehto M, Sundvall J, Salomaa V: Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care 2011,34:392-397.
5. Brun P, Castagliuolo I, Di Leo V, Buda A, Pinzani M, Palu G, Martines D: Increased intestinal permeability in obese mice: new evidence on the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007,292:G518-525.
6. Chang S, Li L: Metabolic endotoxemia: A Novel Concept in Chronic Disease Pathology. J Med Sci 2011,31(5):191-209.
7. Klein GL, Petschow BW, Shaw AL, Weaver E: Gut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target. Curr Opin Support Palliat Care 2013,7(4):361-367.
8. Wang B, Wu G, Zhou Z, Dai Z, Sun Y, Ji Y, Li W, Wang W, Liu C, Han F, Wu Z. Glutamine and intestinal barrier function. Amino Acids 2014 Jun 26. [Eub ahead of print].
9. Meracado J, Valenzano MC, Jeffers C, Sediak J, Cugliari MK et al. Enhancement of Tight Junctional Barrier Function by Micronutrients: Compound Specific Effects on Permeability and Claudin Composition. PLoS One 2013, 8(11):e78775
10. Mahmood A, Fitzgerald AJ, Marchbank T, Ntatsaki E, Murray D, Ghosh S, Playford RJ. Zinc carnosine, a health food supplement that stabilizes small bowel integrity and stimulates gut repair processes. Gut 2007, 56:168-175
11. Thomas CM, Versalovic J: Probiotics-host communication. Modulation of signaling pathways in the intestine. Gut Microbes 2010,1(3):148-163.
12. Bermudez-Brito M, Plaza-Diaz J, Munoz-Quezada S, Gomez-Llorente C, Gil A: Probiotic Mechanisms of Action. Ann Nutr Metab 2012,61:160-174.
13. Menard S, Candalh C, Bambou JC, Terpend K, Cerf-Bensussan N, Heyman M. Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut 2004,53:821-828.
14. Heyman M, Terpend K, Menard S. Effects of specific lactic acid bacteria on the intestinal permeability to macromolecules and the inflammatory condition. Acta Paediatr Suppl 2005,94(449):34-36.
15. Donato KA, Gareau M, Wang YJ, Sherman PM. Lactobacillus rhamnosus GG attenuates interferon-{gamma} and tumor necrosis factor-a-induced barrier dysfunction and proinflammatory signalling. Microbiology 2010,156:3288-3297.
16. Ukena SN, Singh A, Dringenberg U, Engelhardt R, Seideler U, Hansen W, Bleich A, Bruder D, Franzke A, Rogler G, Suerbaum S, Buer J, Gunzer F, Westendorf AM. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS One 2007,12(2):e1308.
17. Anderson RC, Cookson AL, McNabb WC, Park Z, McCann MJ, Kelly WJ, Roy NC. Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation. BMC Microbiol 2010,10:316.
18. Rao RK, Samak G. Protection and Restitution of Gut Barrier by Probiotics: Nutritional and Clinical Implications. Curr Nutr Food Sci 2013,9(2):99-107.
19. Ohland CL, MacNaughton WK. Probiotic bacteria and intestinal barrier function. Am J Physiol Gastrointest Liver Physiol 2010;298:G807-G819.
20. Khailova L, Frank DN, Dominguez JA, Wischmeyer PE. Probiotic administration reduces mortality and improves intestinal epithelial homeostasis in experimental sepsis. Anesthesiology 2013,119(1):166-177.
21. Forsyth CB, Farhadi A, Jakate SM, Tang Y, Shaikh M, Keshavarzian A. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol 2009,43(2):163-172.
22. Sindhu KN, Sowmyanarayanan TV, Paul A, Baji S, Ajjampur SS, Priyadarshini S, Sarkar R, Balasubramanian KA, Wanke CA, Ward HD, Kang G. Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG (LGG): a randomized, double-blinded, placebo-controlled trial. Clin Infect. Dis 2014, 58(8):1107-1115.
23. Shing CM, Peake JM, Lim CL, Briskey D, Walsh NP, Fortes MB, Ahuja KD, Vitetta L. Effects of probiotic supplementation on gastrointestinal permeability, inflammation and exercise performance in the heat. Eur J Appl Physiol 2014,114(1):93-103.
24. Lamprecht M, Bogner S, Schippinger G, Steinbauer K, Fankhauser F, Hallstroem S, Schuetz B, Greilberger JF. Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained med; a randomized, double-blinded, placebo-controlled trial. J Int Soc Sports Nutr 2012,9(1):45.
25. Garcia Vilela E, De Lourdes De Abreu Ferrari M, Oswaldo Da Gama Torres H, Guerra Pinto A, Carolina Carneiro Aguirre A, Paiva Martins F, Marcos Andradr Goulart E, Sales Da Cunha A. Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease with remission. Scand J Gastroenterol 2008,43(7):842-848.
26. Rosenfeldt V, Benfeldt E, Valerius NH, Paerregaard A, Michaelsen KF. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J Pediatr 2004,145(5):612-616.
27. Zeng J, Li YQ, Zuo XL, Zhen YB, Yang J, Lui CH. Clinical trial: effect of lactic acid bacteria on mucosal barrier function in patients with diarrhea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2008,28(8):994-1002.
28. Vinolo MA, Rodrigues HG, Nachbar RT, Curi R. Regulation of inflammation by Short Chain Fatty Acids. Nutrients 2011,3:858-876.
29. Chang PV, Hoa L, Offermanns S. Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA 2014,111(6):2247-2252.
30. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Takahashi M, Fukuda NN, Murakami S, Miyauchi E, Hino S, Atarashi K, Onawa S, Fujimura Y, Lockett T, Clarke JM, Topping DL, Tomita M, Hori S, Ohara O, Morita T, Koseki H, Kikichi J, Honda K, Hase K, Ohno H. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013,504(7480):446-450.
31. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, Liu H, Cross JR, Pfeffer K, Coffer PJ, Rudensky AY. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013, 504(7480):451-455.
32. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 2008,27:104-119.
33. Viera AT, Teixeira MM, Martins FS. The role of probiotics and prebiotics in inducing gut immunity. Frontiers Immunol 2013,445(4):1-12.
34. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002,415:389-395.
35. Martin E, Ganz T, Lehrer RI. Defensins and other endogenous peptide antibiotics of vertebrates. J Leukocyt Biol 1995,58(2):128-136.
36. Gallo RL, Nakatsuji T. Microbial symbiosis with the innate immune defense system of the skin. J Invest Dermatol 2011,131(10):1974-1980.
37. Schroder JM. The role of keratinocytes in defense against infection. Curr Opin Infect Dis 2010,23(2):106-110.
38. Rogan MP, Geraghty P, Greene CM, O'Neill SJ, Taggart CC, McElvaney NG. Antimicrobial proteins and polypeptides in pulmonary innate defense. Respir Res 7:29.
39. Elsbach P. What is the real role of antimicrobial polypeptides that can mediate several other inflammatory responses? J Clin Invest 200,111(11):1643-1645.
40. Bowdish DM, Davidson DJ, Hancock RE. Immunomodulatory properties of defensins and cathelicidins. Curr Top Microbiol Immunol 2006,306:27-66.
41. Schauber J, Gallo RL. Expanding the roles of antimicrobial peptides in skin: alarming and arming keratinocytes. J Invest Dermatol 2007,127(3):510-512.
42. Campbell EL, Serhan CN, Colgan SP. Antimicrobial Aspects of Inflammatory Resolution in the Mucosa: A Role for Proresolving mediators. J Immunol 2011,187:3475-3481.
43. Dombrowksi Y, Peric M, Koglin S, Ruzicka T, Schauber J. Control of cutaneous antimicrobial peptides by vitamin D3. Arch Dermatol Res 2010,302(6):401-408.
44. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, Tavera_Mednoza L, Lin R, Hanrahan JW, Mader S, White JH. Cutting Edge: 1,25-Dihydroxyvitamin D3 is a Direct Inducer of Antimicrobial Peptide Gene Expression. J Immunol 2004,173(5):2909-2912.
45. Sherman H, Chapnik N, Froy O. Albumin and amino acids upregulate the expression of human beta-defensin 1. Mol Immunol 2006,43(10):1617-1623.
46. Zasloff M. Inducing endogenous antimicrobial peptides to battle infections. Proc Natl Acad Sci USA. 2006,103(2):8913-8914.
47. Schlee M, Harder J, Koten B, Stange EF, Wehkamp J, Fellermann K. Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2. Clin Exp Immunol 2008,151(3):528-535.
48. Dobson A, Cotter PD, Ross RP, Hill C. Bacteriocin Production: a Probiotic trait. Appl Environ Microbiol 2012;78(1):1-6.
49. Villena J, Kitazawa H. Modulation of intestinal TLR4-inflammatory signaling pathways by probiotic microorganisms: lessons learned from Lactobacillus jensenii TL2937. Front Immunol 2014; 4(512):1-12.
50. Dogi CA, Weill F, Perdigon G. Immune response of non-pathogenic Gram(+) and Gram (-) bacteria in inductive sites of the intestinal mucosa study of the pathway of signaling involved. Immunobiology 2010,215(1):60-69.
51. Schroder K, Tschopp J. The inflammasomes. Cell 2010,140:821-832.
52. Smits HH, Engering A, van der Kleij, de Jong EC, Schipper K, van Capel TM, Zaat BA, Yazdanbakshs M, Wierenga EA, van Kooyk Y, Kapsenberg ML. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 2005, 115(6):1260-7.
53. Hseih PS, An Y, Tsai YC, Chen YC, Chunag CJ, Zeng CT, Want CT, An-Eri King V. Potential of probiotic strains to modulate the inflammatory responses of epithelial and immune cells in vitro. New Microbiol 2012,36(2):167-179.
54. Oksaharuju A, Kooistra T, Kleemann R, van Duyvenvoorde W, Miettinen M, Lappalainen J, Lindstedt KA, Kovanen PT, Korpela R, Kekkonen RA. Effects of probiotic Lactobacillus rhamnosus GG and Proprionibacterium freudenreichii ssp. shermani JS supplementation on intestinal and systemic markers of inflammation in ApoE*3Leiden mice consuming a high-fat diet. Br J Nutr 2013,119(1):77-85.
55. Di Giacinto CD, Marinaro M, Sanchez M, Strober W, Boirivant M. Probiotics ameliorate recurrent Th-1 mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-b bearing regulatory cells. J Immunol 2005,174:3237-3246.
56. Calcinaro F, Dionisi S, Marinaro M, Candeloro P, Bonat V, Marzotti S, Corneli RB, Ferretti E, Gulino A, Grasso F, De Simone C, Di Mario U, Falorni A, Boirivant M, Dotta F. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 2005;48(8):1565-75.
57. Jeon SG, Kayama H, Ueda Y, Takahashi T, Asahara T, Tsuji H, Tsuji NM, Kiyono H, Ma JS, Kusu T, Okumura R, Hara H, Yoshida H, Yamamoto M, Nomoto K, Takeda K. Probiotic Bifidobacterium breve Induces IL-10-Producing Tr1 Cells in the Colon. PLoS Pathog 2012,8(5):e1002714.
58. Timmerman HM, Koning CJ, Mukder L, Rombouts FM, Beynen AC. Monostrain, multistrain and multispecies probiotics-A comparison of functionality and efficacy. Int J Food Microbiol 2004,96(3):219-233.
59. Kekkonen RA, Lummela N, Karjalainen H, Latvala S, Tynkkynen S, Jarvenpaa S, Kautiainen H, Julkunen I, Vapaatalo H, Korpela R. Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults. World J Gastroenterol 2008,14(13):2029-2036.
60. Asemi Z, Jazayeri S, Najafi M, Samimi M, Mofid V, Shidfar F, Foroushani AR, Shahaboddin ME. Effects of daily consumption of probiotic yogurt on inflammatory factors in pregnant women: a randomized controlled trial. Pak J Biol Sci 2011,14(8):476-482.
61. Sanaie S, Ebrahimi-Mameghani M, Mahmoodpoor A, Shadvar K, Golzari SE. Effect of a Probiotic Preparation (VSL#3) on Cardiovascular Risk Parameters in Critically-Ill Patients. J Cardiovasc Thorac Res 2013,5(2):67-70.
62. Shadnoush M, Shaker Hosseini R, Mehrabi Y, Delpisheh A, Alipoor E, Faghfoori Z, Mohammadpour N, Zaringhalam Moghadam J. Probiotic yogurt affects pro- and ant-inflammatory factors in patients with inflammatory bowel disease. Iran J Pharm Res 2013,12(4):929-936.
63. Groeger D, O'Mahony L, Murphy EF, Bourke JF, Dinan TG, Kiely B, Shanahan F, Quigley EM. Bifidobacterium infantis 35624 modulates inflammatory processes beyond the gut. Gut Microbes 2013,4(4):325-339.
64. Asemi Z, Zare Z, Shakeri H Sabihi SS, Esmaillzaden A. Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann Nutr Metabol 2013,63(1-2):1-9.
65. Review Team, Guarner F, Khan AG, Garisch J, Eliakim R, Gangl A, Thomson A, Krabshius J, Lemair T, Kaufmann P, Andres de Paula J, Fedorak R, Shanahan F, Sanders Mary Ellen, Hania Szajewska, Siddartha Ramakrishna B, Karakan T, Kim N. World Gastroenterology Organization Global Guidelines. Probiotics and Prebiotics. October 2011. J Clin Gastroenterol 2012;46(6):468-481.